SCHEMBL3798034

SCHEMBL3798034

O=C(NC1CCN(Cc2cccnc2)C(I)C1)c1ccc(OC2CCN(c3ccc(C(F)(F)F)cc3)CC2)cn1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC6A5 Q9Y345 2/20 0.50
HIF1A Q16665 5/20 0.41
EPAS1 Q99814 5/20 0.41
FFAR1 O14842 1/20 0.40
KCNH2 Q12809 1/20 0.40
MCHR1 Q99705 1/20 0.40
PRKAA2 P54646 8/20 0.39
LPL P06858 1/20 0.39
LIPG Q9Y5X9 1/20 0.39
PRKAB2 O43741 1/20 0.38
CYP3A4 P08684 1/20 0.38
PRKAG1 P54619 1/20 0.38
PRKAA1 Q13131 1/20 0.38
PRKAG3 Q9UGI9 1/20 0.38
PRKAG2 Q9UGJ0 1/20 0.38
PRKAB1 Q9Y478 1/20 0.38
CHRM4 P08173 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3799739 0.89 PRKAA2 (0.51) PRKAA2PRKAB2CYP3A4PRKAG1PRKAA1
SCHEMBL647670 0.89 SLC6A5 (0.64) SLC6A5HIF1AEPAS1KCNH2MCHR1
SCHEMBL3801004 0.88 PRKAA2 (0.53) PRKAA2PRKAB2CYP3A4PRKAG1PRKAA1
SCHEMBL3665414 0.88 SLC6A5 (0.50) SLC6A5HIF1AEPAS1FFAR1KCNH2
SCHEMBL3662664 0.86 SLC6A5 (0.46) SLC6A5HIF1AEPAS1FFAR1KCNH2
SCHEMBL3668577 0.85 SLC6A5 (0.45) SLC6A5HIF1AEPAS1FFAR1KCNH2
SCHEMBL3660163 0.84 F10 (0.39) SLC6A5KCNH2PRKAA2LPLLIPG
SCHEMBL3662737 0.83 MDM2 (0.41) SLC6A5PRKAA2
SCHEMBL3666697 0.82 PRKAA2 (0.43) SLC6A5FFAR1PRKAA2PRKAB2PRKAG1
SCHEMBL648104 0.81 SLC6A5 (0.53) SLC6A5PRKAA2PRKAB2CYP3A4PRKAG1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2231600-A1 CARBOXAMIDE, SULFONAMIDE AND AMINE COMPOUNDS FOR METABOLIC DISORDERS Rigel Pharmaceuticals, Inc. (US) 2010-09-29 EP claimed
WO-2009065131-A1 CARBOXAMIDE, SULFONAMIDE AND AMINE COMPOUNDS FOR METABOLIC DISORDERS RIGEL PHARMACEUTICALS, INC. (US) 2009-05-22 WO claimed